Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 242 entries
View as:

Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04506138 Org: User:
Start: 08/11/20 End: 12/31/25 Due: 12/31/26

A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for ES-SCLC

Phase: N/A Priority: Normal
NCT ID: NCT06478043 Org: User:
Start: 09/01/24 End: 09/01/27 Due: 09/01/28

Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03204734 Org: User:
Start: 01/01/16 End: 12/30/21 Due: 12/30/22

Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients（PRECISION）

Phase: N/A Priority: Normal
NCT ID: NCT06711432 Org: User:
Start: 09/18/24 End: 06/01/26 Due: 06/01/27

Ciprofol EC50 for Inducing Loss of Consciousness in Elderly Patients

Phase: N/A Priority: Normal
NCT ID: NCT06253078 Org: User:
Start: 04/02/24 End: 12/30/25 Due: 12/30/26

Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04808752 Org: User:
Start: 07/09/21 End: 07/15/24 Due: 07/15/25

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03907098 Org: User:
Start: 06/30/16 End: 06/30/20 Due: 06/30/21

PET/MR in Locally Advanced Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03657017 Org: User:
Start: 06/01/18 End: 12/30/25 Due: 12/30/26

Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03058432 Org: User:
Start: 01/31/17 End: 12/31/19 Due: 12/31/20

Pharmacokinetic Study of Tranexamic Acid

Phase: N/A Priority: Normal
NCT ID: NCT06728670 Org: User:
Start: 11/20/24 End: 08/31/25 Due: 08/31/26

Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor

Phase: N/A Priority: Normal
NCT ID: NCT05502458 Org: User:
Start: 12/01/20 End: 08/08/22 Due: 08/08/23

Single Cell Sequencing Analysis of Thymoma

Phase: N/A Priority: Normal
NCT ID: NCT04162691 Org: User:
Start: 06/06/20 End: 12/31/23 Due: 12/31/24

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06300489 Org: User:
Start: 03/03/24 End: 10/31/25 Due: 10/31/26

Anterior Quadratus Lumborum Block at the Lateral Supra-arcuate Ligament for Analgesia After Open Liver Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04668391 Org: User:
Start: 12/17/20 End: 07/02/21 Due: 07/02/22

Individualized Pharmaceutical-care in Outpatients With Cancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT03439904 Org: User:
Start: 06/30/18 End: 06/30/19 Due: 06/30/20

A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801)

Phase: N/A Priority: Normal
NCT ID: NCT00886678 Org: User:
Start: 07/31/08 End: 07/31/10 Due: 07/31/11

Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients

Phase: N/A Priority: Normal
NCT ID: NCT06650332 Org: User:
Start: 07/10/24 End: 12/30/27 Due: 12/30/28

A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04860674 Org: User:
Start: 05/01/21 End: 04/01/24 Due: 04/01/25

A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC

Phase: N/A Priority: Normal
NCT ID: NCT04543890 Org: User:
Start: 05/01/18 End: 06/01/25 Due: 06/01/26

A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02570893 Org: User:
Start: 05/31/15 End: 10/31/20 Due: 10/31/21

Monosialoganglioside Ganglioside in Cerebral Radiation Necrosis

Phase: N/A Priority: Normal
NCT ID: NCT03067753 Org: User:
Start: 12/31/16 End: 09/30/19 Due: 09/30/20

Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05564897 Org: User:
Start: 08/26/22 End: 12/31/24 Due: 12/31/25

Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC

Phase: N/A Priority: Normal
NCT ID: NCT05856383 Org: User:
Start: 03/16/22 End: 12/31/27 Due: 12/31/28

GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC

Phase: N/A Priority: Normal
NCT ID: NCT06611826 Org: User:
Start: 09/30/24 End: 12/30/29 Due: 12/30/30

Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT06832267 Org: User:
Start: 02/14/25 End: 02/13/28 Due: 02/13/29